|
|
||||||||
Anecdotal historical evidence suggests that tuberculosis was uncommon at high altitude, but whether transmission is affected by high altitude is not known. To test whether high altitude lowers infection by Mycobacterium tuberculosis, the prevalence of tuberculin skin test (TST) positivity was compared between two high altitude villages (3,340 meters [10,960 feet] and 3,500 meters [11,480 feet]) and three sea-level sites in Peru. High altitude villages had lower TST-positive prevalence rates (5.7% and 6.8%) than sea level areas (2533%), and the difference remained significant (odds ratio = 4.56.0) after adjusting for age, education, bacille Calmette-Guérin vaccination, and contact with tuberculosis patients. The TST-positive individuals clustered within highland families more than within sea level families. These data suggest that prevention and control efforts targeted to families may be more effective at high altitude. The mechanism by which TST-positivity prevalence is decreased at high altitude is unknown, but may reflect relative hypoxia, low humidity, or an increased ultraviolet effect.
Received October 1, 2002. Accepted for publication March 3, 2003.
Acknowledgments: We thank Drs. Carlton Evans, Lawrence Moulton, Richard Oberhelman, Yutaka Aoki, and Dimitris Placantonakis for their advice on this paper and comments on the manuscript; Jenny Centeno and Pamela Limo for preparation of the map; Marco Varela for data management; and J. B. Phu, D. Sara, E. Talula for technical support. We also thank the communities of Quilcas, Vichaycocha, Las Pampas de San Juan de Miraflores, San Carlos, and Buen Pastor for their cooperation.
Financial support: This study was supported by the United States Agency for International Development Tuberculosis Award HRN-5986-A-00-6006-00, National Institutes of Health (NIH) International Training and Research in Emerging Infectious Diseases grant 5D43
Authors addresses: Susan Olender, Mayuko Saito, Jane Apgar, Kari Guillenwater, Christian T. Bautista, Andres G. Lescano, Pedro Moro, Luz Caviedes, and Evelyn J. Hsieh, A.B. PRISMA Carlos Gonzales 251, Urb. Maranga, San Miguel, Lima 32, Peru, Telephone: 51-1-464-0221, Fax: 51-1-464-0781. Robert H. Gilman, Department of International Health, The Johns Hopkins School of Public Health, 615 North Wolfe Street, Room W3503, Baltimore, MD 21205, Telephone: 410-614-3959, Fax: 410-614-6060, E-mail: rgilman{at}jhsph.edu.
This article has been cited by other articles:
![]() |
Ma. C. Garcia-Sancho F, L. Garcia-Garcia, Ma. E. Jimenez-Corona, M. Palacios-Martinez, L. D Ferreyra-Reyes, S. Canizales-Quintero, B. Cano-Arellano, A. Ponce-de-Leon, J. Sifuentes-Osornio, P. Small, et al. Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG-vaccinated children? Int. J. Epidemiol., December 1, 2006; 35(6): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SAITO, W. K. PAN, R. H. GILMAN, C. T. BAUTISTA, S. BAMRAH, C. A. MARTIN, S. J. TSIOURIS, D. F. ARGUELLO, and G. MARTINEZ-CARRASCO COMPARISON OF ALTITUDE EFFECT ON MYCOBACTERIUM TUBERCULOSIS INFECTION BETWEEN RURAL AND URBAN COMMUNITIES IN PERU. Am J Trop Med Hyg, July 1, 2006; 75(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |